These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 25456159
1. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Skabytska Y, Wölbing F, Günther C, Köberle M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T, Rammensee HG, Schaller M, Röcken M, Götz F, Biedermann T. Immunity; 2014 Nov 20; 41(5):762-75. PubMed ID: 25456159 [Abstract] [Full Text] [Related]
2. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. Kaesler S, Volz T, Skabytska Y, Köberle M, Hein U, Chen KM, Guenova E, Wölbing F, Röcken M, Biedermann T. J Allergy Clin Immunol; 2014 Jul 20; 134(1):92-9. PubMed ID: 24698321 [Abstract] [Full Text] [Related]
3. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. Maruyama A, Shime H, Takeda Y, Azuma M, Matsumoto M, Seya T. Biochem Biophys Res Commun; 2015 Feb 13; 457(3):445-50. PubMed ID: 25596131 [Abstract] [Full Text] [Related]
4. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice. Schmid M, Zimara N, Wege AK, Ritter U. Eur J Immunol; 2014 Nov 13; 44(11):3295-306. PubMed ID: 25142017 [Abstract] [Full Text] [Related]
5. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Schouppe E, Mommer C, Movahedi K, Laoui D, Morias Y, Gysemans C, Luyckx A, De Baetselier P, Van Ginderachter JA. Eur J Immunol; 2013 Nov 13; 43(11):2930-42. PubMed ID: 23878002 [Abstract] [Full Text] [Related]
6. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. Vu AT, Baba T, Chen X, Le TA, Kinoshita H, Xie Y, Kamijo S, Hiramatsu K, Ikeda S, Ogawa H, Okumura K, Takai T. J Allergy Clin Immunol; 2010 Nov 13; 126(5):985-93, 993.e1-3. PubMed ID: 21050945 [Abstract] [Full Text] [Related]
7. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway. Liu Y, Zhang L, Zhu X, Wang Y, Liu W, Gong W. Immunology; 2015 Nov 13; 146(3):379-91. PubMed ID: 26194418 [Abstract] [Full Text] [Related]
8. Staphylococcus aureus-derived lipoteichoic acid induces temporary T-cell paralysis independent of Toll-like receptor 2. Kaesler S, Skabytska Y, Chen KM, Kempf WE, Volz T, Köberle M, Wölbing F, Hein U, Hartung T, Kirschning C, Röcken M, Biedermann T. J Allergy Clin Immunol; 2016 Sep 13; 138(3):780-790.e6. PubMed ID: 26949056 [Abstract] [Full Text] [Related]
10. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection. Pandey SP, Chandel HS, Srivastava S, Selvaraj S, Jha MK, Shukla D, Ebensen T, Guzman CA, Saha B. J Immunol; 2014 Oct 01; 193(7):3632-43. PubMed ID: 25194056 [Abstract] [Full Text] [Related]
11. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Cabanski M, Steinmüller M, Marsh LM, Surdziel E, Seeger W, Lohmeyer J. Am J Respir Cell Mol Biol; 2008 Jan 01; 38(1):26-31. PubMed ID: 17690330 [Abstract] [Full Text] [Related]
20. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. Immunity; 2009 Dec 18; 31(6):873-84. PubMed ID: 19931471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]